Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence

Background: Geniposide, as a pharmacologically bioactive component, is derived from a classic and common Chinese herb, Gardenia jasminoides Ellis. Geniposide has been shown to be effective for treating I/R injury in recent studies. Current effectively pharmaceutical treatments are scarce, and treatm...

Full description

Bibliographic Details
Main Authors: Chaoqin Luo, Lingfeng Wang, Yifan Wu, Menghan Liu, Baoxin Chen, Yuqiao Lu, Yunling Zhang, Chen Fu, Xuemei Liu
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402307322X
_version_ 1797669705990799360
author Chaoqin Luo
Lingfeng Wang
Yifan Wu
Menghan Liu
Baoxin Chen
Yuqiao Lu
Yunling Zhang
Chen Fu
Xuemei Liu
author_facet Chaoqin Luo
Lingfeng Wang
Yifan Wu
Menghan Liu
Baoxin Chen
Yuqiao Lu
Yunling Zhang
Chen Fu
Xuemei Liu
author_sort Chaoqin Luo
collection DOAJ
description Background: Geniposide, as a pharmacologically bioactive component, is derived from a classic and common Chinese herb, Gardenia jasminoides Ellis. Geniposide has been shown to be effective for treating I/R injury in recent studies. Current effectively pharmaceutical treatments are scarce, and treatment based on geniposide may become a novel option. As far as we know, this research is the initial systematic evaluation of the protective effects of geniposide in I/R injury. Aim of the study: This study is engrossed in evaluating the mechanism of action of geniposide in I/R injury through a preclinical systematic review with meta-analysis and network pharmacology. Materials and methods: We built a systematic review which provided a view of effect and mechanism of geniposide for I/R injury. Based on seven databases, an open-ended search from their inception to August 31st, 2022, was conducted. Animal studies on the effects of geniposide in I/R injury were considered. The data was analyzed using Review Manager 5.3, and bias was assessed using the CAMARADES 10-item scale. 13 articles including 279 animals were selected finally. And network pharmacology was joined to elucidate the mechanism. Results: According to the meta-analysis, in I/R injury, geniposide can attenuate cardiomyocytes viability and the size of MI, decrease the volume of cerebral infraction and neurological score, decrease serum ALT and AST activity, and downregulated serum Cr and BUN. The review found that geniposide protects against I/R injury by inhibiting apoptosis, oxidation, inflammation and improvement of autophagy and mitochondrial respiration, which is consistent with the results of the network pharmacology screening. Conclusion: This preclinical systematic review including meta-analysis and network pharmacology, which was the first one summarizing the relationship between geniposide and ischemia diseases, shows a novel therapy for I/R injury and appears an enticing implication of geniposide in I/R injury, and further research is looked forward. Given the restricted quantity of included researches and the unclear risk of bias of the studies, we should interpret the results with caution.
first_indexed 2024-03-11T20:48:22Z
format Article
id doaj.art-64ae3ff1c9f649b88137969f3c5c5096
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-11T20:48:22Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-64ae3ff1c9f649b88137969f3c5c50962023-10-01T06:02:37ZengElsevierHeliyon2405-84402023-09-0199e20114Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidenceChaoqin Luo0Lingfeng Wang1Yifan Wu2Menghan Liu3Baoxin Chen4Yuqiao Lu5Yunling Zhang6Chen Fu7Xuemei Liu8Beijing University of Chinese Medicine, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaBeijing University of Chinese Medicine, Beijing, ChinaNeurology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, ChinaOffice of Academic Research, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, ChinaDepartment of Neurology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaExperimental Center of Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China; Corresponding author.Office of Academic Research, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China; Corresponding author.Background: Geniposide, as a pharmacologically bioactive component, is derived from a classic and common Chinese herb, Gardenia jasminoides Ellis. Geniposide has been shown to be effective for treating I/R injury in recent studies. Current effectively pharmaceutical treatments are scarce, and treatment based on geniposide may become a novel option. As far as we know, this research is the initial systematic evaluation of the protective effects of geniposide in I/R injury. Aim of the study: This study is engrossed in evaluating the mechanism of action of geniposide in I/R injury through a preclinical systematic review with meta-analysis and network pharmacology. Materials and methods: We built a systematic review which provided a view of effect and mechanism of geniposide for I/R injury. Based on seven databases, an open-ended search from their inception to August 31st, 2022, was conducted. Animal studies on the effects of geniposide in I/R injury were considered. The data was analyzed using Review Manager 5.3, and bias was assessed using the CAMARADES 10-item scale. 13 articles including 279 animals were selected finally. And network pharmacology was joined to elucidate the mechanism. Results: According to the meta-analysis, in I/R injury, geniposide can attenuate cardiomyocytes viability and the size of MI, decrease the volume of cerebral infraction and neurological score, decrease serum ALT and AST activity, and downregulated serum Cr and BUN. The review found that geniposide protects against I/R injury by inhibiting apoptosis, oxidation, inflammation and improvement of autophagy and mitochondrial respiration, which is consistent with the results of the network pharmacology screening. Conclusion: This preclinical systematic review including meta-analysis and network pharmacology, which was the first one summarizing the relationship between geniposide and ischemia diseases, shows a novel therapy for I/R injury and appears an enticing implication of geniposide in I/R injury, and further research is looked forward. Given the restricted quantity of included researches and the unclear risk of bias of the studies, we should interpret the results with caution.http://www.sciencedirect.com/science/article/pii/S240584402307322XGeniposideIschemia reperfusionMechanismSystematic reviewMeta-analysisNetwork pharmacology
spellingShingle Chaoqin Luo
Lingfeng Wang
Yifan Wu
Menghan Liu
Baoxin Chen
Yuqiao Lu
Yunling Zhang
Chen Fu
Xuemei Liu
Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence
Heliyon
Geniposide
Ischemia reperfusion
Mechanism
Systematic review
Meta-analysis
Network pharmacology
title Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence
title_full Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence
title_fullStr Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence
title_full_unstemmed Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence
title_short Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence
title_sort protective effect and possible mechanisms of geniposide for ischemia reperfusion injury a systematic review with meta analysis and network pharmacology of preclinical evidence
topic Geniposide
Ischemia reperfusion
Mechanism
Systematic review
Meta-analysis
Network pharmacology
url http://www.sciencedirect.com/science/article/pii/S240584402307322X
work_keys_str_mv AT chaoqinluo protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT lingfengwang protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT yifanwu protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT menghanliu protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT baoxinchen protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT yuqiaolu protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT yunlingzhang protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT chenfu protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence
AT xuemeiliu protectiveeffectandpossiblemechanismsofgeniposideforischemiareperfusioninjuryasystematicreviewwithmetaanalysisandnetworkpharmacologyofpreclinicalevidence